- Home
- All Stock List
- BSE
- Dishman Carbogen Amcis Ltd Share Price
Dishman Carbogen Amcis Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap
266.05
0.10 (0.04%)
-
Outperforms Index
41.97%
Return (1Y)
Beaten BSE Healthcare by 22.46%
-
More Volatile
4%
Standard Deviation (1Y)
Higher than BSE Healthcare by 2.93%
-
Consistent Performer
7/12
Months
beaten BSE Healthcare
-
AxisDirect View
No View
308

133
News & Announcements
-
Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-tax profit before exxceptional items stood at Rs 39.45 crore in Q4 FY25 as against pre-tax loss before exceptional items of Rs 46.11 crore in Q4 FY24.
For the full year, the company reported net profit of Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore in the year ended March 2024. Net sales rose 3.66% YoY to Rs 2711.50 crore in the year ended March 2025. Pre-tax profit before exceptional items stood at Rs 37.42 crore in FY25 as against pre-tax loss before exceptional items of Rs 116.12 crore in FY24.
During the quarter and year ended 31 March 2025, certain subsidiaries discarded some of their inventories, which was not expected to be usable for projects that the company estimated to undertake in near to mid-term. The loss on account of these impairment were Rs 0.77 crore and Rs 7.13 crore respectively for the quarter and year. Further, during the quarter ended 31 March 2025, one of the subsidiaries Carbogen Amcis AG, had impaired expenditure incurred for capex project. The loss on account of this impairment was Rs 10.98 crore for the quarter and the year.
The company's consolidated net cash from operating activities stood at Rs 375.23 crore in FY25, lower than Rs 379.43 crore in FY24.
Dishman Carbogen Amcis is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It provides a range of development and manufacturing solutions at locations in Europe, China and in India.
Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net profit of Dishman Carbogen Amcis reported to Rs 43.09 crore in the quarter ended March 2025 as against net loss of Rs 69.92 crore during the previous quarter ended March 2024. Sales rose 9.41% to Rs 716.34 crore in the quarter ended March 2025 as against Rs 654.71 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore during the previous year ended March 2024. Sales rose 3.66% to Rs 2711.50 crore in the year ended March 2025 as against Rs 2615.77 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 716.34 654.71 9 2711.50 2615.77 4 OPM % 21.32 9.57 - 17.29 10.95 - PBDT 118.54 38.89 205 331.16 194.74 70 PBT 39.45 -46.11 LP 37.42 -116.12 LP NP 43.09 -69.92 LP 3.24 -153.45 LP Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net Loss of Dishman Carbogen Amcis reported to Rs 7.37 crore in the quarter ended March 2025 as against net loss of Rs 31.12 crore during the previous quarter ended March 2024. Sales declined 4.64% to Rs 106.10 crore in the quarter ended March 2025 as against Rs 111.26 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 9.87 crore in the year ended March 2025 as against net loss of Rs 76.41 crore during the previous year ended March 2024. Sales rose 22.14% to Rs 399.84 crore in the year ended March 2025 as against Rs 327.35 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 106.10 111.26 -5 399.84 327.35 22 OPM % 19.35 10.40 - 17.95 2.08 - PBDT 4.69 -7.51 LP 34.37 1.66 1970 PBT -11.41 -33.63 66 -30.83 -99.95 69 NP -7.37 -31.12 76 -9.87 -76.41 87 Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net profit of Dishman Carbogen Amcis reported to Rs 43.09 crore in the quarter ended March 2025 as against net loss of Rs 69.92 crore during the previous quarter ended March 2024. Sales rose 9.41% to Rs 716.34 crore in the quarter ended March 2025 as against Rs 654.71 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore during the previous year ended March 2024. Sales rose 3.66% to Rs 2711.50 crore in the year ended March 2025 as against Rs 2615.77 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 716.34 654.71 9 2711.50 2615.77 4 OPM % 21.32 9.57 - 17.29 10.95 - PBDT 118.54 38.89 205 331.16 194.74 70 PBT 39.45 -46.11 LP 37.42 -116.12 LP NP 43.09 -69.92 LP 3.24 -153.45 LP Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net Loss of Dishman Carbogen Amcis reported to Rs 7.37 crore in the quarter ended March 2025 as against net loss of Rs 31.12 crore during the previous quarter ended March 2024. Sales declined 4.64% to Rs 106.10 crore in the quarter ended March 2025 as against Rs 111.26 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 9.87 crore in the year ended March 2025 as against net loss of Rs 76.41 crore during the previous year ended March 2024. Sales rose 22.14% to Rs 399.84 crore in the year ended March 2025 as against Rs 327.35 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 106.10 111.26 -5 399.84 327.35 22 OPM % 19.35 10.40 - 17.95 2.08 - PBDT 4.69 -7.51 LP 34.37 1.66 1970 PBT -11.41 -33.63 66 -30.83 -99.95 69 NP -7.37 -31.12 76 -9.87 -76.41 87 Powered by Capital Market - Live News
-
Dishman Carbogen Amcis to hold board meeting
15 days ago
-
Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-tax profit before exxceptional items stood at Rs 39.45 crore in Q4 FY25 as against pre-tax loss before exceptional items of Rs 46.11 crore in Q4 FY24.
For the full year, the company reported net profit of Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore in the year ended March 2024. Net sales rose 3.66% YoY to Rs 2711.50 crore in the year ended March 2025. Pre-tax profit before exceptional items stood at Rs 37.42 crore in FY25 as against pre-tax loss before exceptional items of Rs 116.12 crore in FY24.
During the quarter and year ended 31 March 2025, certain subsidiaries discarded some of their inventories, which was not expected to be usable for projects that the company estimated to undertake in near to mid-term. The loss on account of these impairment were Rs 0.77 crore and Rs 7.13 crore respectively for the quarter and year. Further, during the quarter ended 31 March 2025, one of the subsidiaries Carbogen Amcis AG, had impaired expenditure incurred for capex project. The loss on account of this impairment was Rs 10.98 crore for the quarter and the year.
The company's consolidated net cash from operating activities stood at Rs 375.23 crore in FY25, lower than Rs 379.43 crore in FY24.
Dishman Carbogen Amcis is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It provides a range of development and manufacturing solutions at locations in Europe, China and in India.
Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net profit of Dishman Carbogen Amcis reported to Rs 43.09 crore in the quarter ended March 2025 as against net loss of Rs 69.92 crore during the previous quarter ended March 2024. Sales rose 9.41% to Rs 716.34 crore in the quarter ended March 2025 as against Rs 654.71 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore during the previous year ended March 2024. Sales rose 3.66% to Rs 2711.50 crore in the year ended March 2025 as against Rs 2615.77 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 716.34 654.71 9 2711.50 2615.77 4 OPM % 21.32 9.57 - 17.29 10.95 - PBDT 118.54 38.89 205 331.16 194.74 70 PBT 39.45 -46.11 LP 37.42 -116.12 LP NP 43.09 -69.92 LP 3.24 -153.45 LP Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net Loss of Dishman Carbogen Amcis reported to Rs 7.37 crore in the quarter ended March 2025 as against net loss of Rs 31.12 crore during the previous quarter ended March 2024. Sales declined 4.64% to Rs 106.10 crore in the quarter ended March 2025 as against Rs 111.26 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 9.87 crore in the year ended March 2025 as against net loss of Rs 76.41 crore during the previous year ended March 2024. Sales rose 22.14% to Rs 399.84 crore in the year ended March 2025 as against Rs 327.35 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 106.10 111.26 -5 399.84 327.35 22 OPM % 19.35 10.40 - 17.95 2.08 - PBDT 4.69 -7.51 LP 34.37 1.66 1970 PBT -11.41 -33.63 66 -30.83 -99.95 69 NP -7.37 -31.12 76 -9.87 -76.41 87 Powered by Capital Market - Live News
-
Dishman Carbogen Amcis to hold board meeting
15 days ago
-
Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-tax profit before exxceptional items stood at Rs 39.45 crore in Q4 FY25 as against pre-tax loss before exceptional items of Rs 46.11 crore in Q4 FY24.
For the full year, the company reported net profit of Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore in the year ended March 2024. Net sales rose 3.66% YoY to Rs 2711.50 crore in the year ended March 2025. Pre-tax profit before exceptional items stood at Rs 37.42 crore in FY25 as against pre-tax loss before exceptional items of Rs 116.12 crore in FY24.
During the quarter and year ended 31 March 2025, certain subsidiaries discarded some of their inventories, which was not expected to be usable for projects that the company estimated to undertake in near to mid-term. The loss on account of these impairment were Rs 0.77 crore and Rs 7.13 crore respectively for the quarter and year. Further, during the quarter ended 31 March 2025, one of the subsidiaries Carbogen Amcis AG, had impaired expenditure incurred for capex project. The loss on account of this impairment was Rs 10.98 crore for the quarter and the year.
The company's consolidated net cash from operating activities stood at Rs 375.23 crore in FY25, lower than Rs 379.43 crore in FY24.
Dishman Carbogen Amcis is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It provides a range of development and manufacturing solutions at locations in Europe, China and in India.
Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net profit of Dishman Carbogen Amcis reported to Rs 43.09 crore in the quarter ended March 2025 as against net loss of Rs 69.92 crore during the previous quarter ended March 2024. Sales rose 9.41% to Rs 716.34 crore in the quarter ended March 2025 as against Rs 654.71 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore during the previous year ended March 2024. Sales rose 3.66% to Rs 2711.50 crore in the year ended March 2025 as against Rs 2615.77 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 716.34 654.71 9 2711.50 2615.77 4 OPM % 21.32 9.57 - 17.29 10.95 - PBDT 118.54 38.89 205 331.16 194.74 70 PBT 39.45 -46.11 LP 37.42 -116.12 LP NP 43.09 -69.92 LP 3.24 -153.45 LP Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net Loss of Dishman Carbogen Amcis reported to Rs 7.37 crore in the quarter ended March 2025 as against net loss of Rs 31.12 crore during the previous quarter ended March 2024. Sales declined 4.64% to Rs 106.10 crore in the quarter ended March 2025 as against Rs 111.26 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 9.87 crore in the year ended March 2025 as against net loss of Rs 76.41 crore during the previous year ended March 2024. Sales rose 22.14% to Rs 399.84 crore in the year ended March 2025 as against Rs 327.35 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 106.10 111.26 -5 399.84 327.35 22 OPM % 19.35 10.40 - 17.95 2.08 - PBDT 4.69 -7.51 LP 34.37 1.66 1970 PBT -11.41 -33.63 66 -30.83 -99.95 69 NP -7.37 -31.12 76 -9.87 -76.41 87 Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports consolidated net profit of Rs 43.09 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net profit of Dishman Carbogen Amcis reported to Rs 43.09 crore in the quarter ended March 2025 as against net loss of Rs 69.92 crore during the previous quarter ended March 2024. Sales rose 9.41% to Rs 716.34 crore in the quarter ended March 2025 as against Rs 654.71 crore during the previous quarter ended March 2024.
For the full year,net profit reported to Rs 3.24 crore in the year ended March 2025 as against net loss of Rs 153.45 crore during the previous year ended March 2024. Sales rose 3.66% to Rs 2711.50 crore in the year ended March 2025 as against Rs 2615.77 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 716.34 654.71 9 2711.50 2615.77 4 OPM % 21.32 9.57 - 17.29 10.95 - PBDT 118.54 38.89 205 331.16 194.74 70 PBT 39.45 -46.11 LP 37.42 -116.12 LP NP 43.09 -69.92 LP 3.24 -153.45 LP Powered by Capital Market - Live News
-
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
10 days ago
Dishman Carbogen Amcis reports standalone net loss of Rs 7.37 crore in the March 2025 quarter
22 - May - 2025 12:00 | 10 days ago
Net Loss of Dishman Carbogen Amcis reported to Rs 7.37 crore in the quarter ended March 2025 as against net loss of Rs 31.12 crore during the previous quarter ended March 2024. Sales declined 4.64% to Rs 106.10 crore in the quarter ended March 2025 as against Rs 111.26 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 9.87 crore in the year ended March 2025 as against net loss of Rs 76.41 crore during the previous year ended March 2024. Sales rose 22.14% to Rs 399.84 crore in the year ended March 2025 as against Rs 327.35 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 106.10 111.26 -5 399.84 327.35 22 OPM % 19.35 10.40 - 17.95 2.08 - PBDT 4.69 -7.51 LP 34.37 1.66 1970 PBT -11.41 -33.63 66 -30.83 -99.95 69 NP -7.37 -31.12 76 -9.87 -76.41 87 Powered by Capital Market - Live News
-
Dishman Carbogen Amcis to hold board meeting
15 days ago
Stock Trivia
FII shareholding in Dishman Carbogen Amcis Ltd has increased by 8.53% since past 3 Months
MF shareholding in Dishman Carbogen Amcis Ltd has decreased by -51.23% since past 1 Year
FII shareholding in Dishman Carbogen Amcis Ltd has increased by 8.53% since past 3 Months
MF shareholding in Dishman Carbogen Amcis Ltd has decreased by -13.54% since past 3 Months
FII shareholding in Dishman Carbogen Amcis Ltd has increased by 9.11% since past 1 Year
MF shareholding in Dishman Carbogen Amcis Ltd has decreased by -51.23% since past 1 Year
FII shareholding in Dishman Carbogen Amcis Ltd has increased by 8.53% since past 3 Months
MF shareholding in Dishman Carbogen Amcis Ltd has decreased by -51.23% since past 1 Year
